DisforDiabetes: Diabetes Trials

Return to the home page of DisforDiabetes

Other sections: Abbreviations — Commentaries — Diabetes Info — Dictionary — Magazines & Journals — Press Releases — Websites

Diabetes Trials

A — B — C — D — E — F — G — H — I — J — K — L — M — N — O —
P — Q — R — S — T — U — V — W — X — Y — Z — 0-9
This listing of diabetes trials is obviously incomplete, as many company-sponsored trials are not listed here. Such trials are usually deemed to be of little importance except to obtain marketing approval from the FDA or other Health Authorities.
Are you aware of other diabetes trials that might be added to this list? If so, please contact us at DisforDiabetes@gmail.com.

Advertisement

ACCORD: Action to Control Cardiovascular Risk in Diabetes (a clinical trial evaluating diabetes control and cardiovascular risk)
(See ACCORD and A1C)

ADVANCE: Action in Diabetes and Vascular disease: PreterAx and DiamicroN MR Controlled Evaluation (a clinical trial evaluating diabetes control and cardiovascular risk)
(See ACCORD and ACCORD and A1C)

APP: Artificial Pancreas Project
(See JDRF Artificial Pancreas Project)

ASPIRE: Automation to Simulate Pancreatic Insulin REsponse
(See Reduction in Duration of Hypoglycemia by Automatic Suspension of Insulin Delivery: The In-Clinic ASPIRE Study)

DCCT: Diabetes Control and Complications Trial
(See DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study)

DPP: Diabetes Prevention Program
(See Diabetes Prevention Program)

DPT-1: Diabetes Prevention Trial--Type 1
(See Diabetes Prevention Trial--Type 1)

DREAM: Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication
(See DREAM home page)

EDIC: Epidemiology of Diabetes Interventions and Complications (a follow-up of the DCCT trial)
(See Epidemiology of Diabetes Interventions and Complications Study (EDIC))

EDIT: Early Diabetes Intervention Trial
(See EDIT home page)

GRADE: Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (a clinical trial to compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin)
(See NIH begins recruitment for long-term study of diabetes drug efficacy)

HPS: Heart Protection Study
(See Study finds statins would cut heart attacks and strokes by a third in people with diabetes)

Look AHEAD: Action for Health in Diabetes
(See Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes)

NICE-SUGAR: Normoglycemia in Intensive Care Evaluation - Survival Using Glucose Algorithm Regulation
(See Tight control of BG in the ICU may be dangerous: the NICE-SUGAR study)

ORIGIN: Outcome Reduction with Initial Glargine Intervention
(See ORIGIN - A Major Diabetes Study that Failed)

PROactive: Prospective Pioglitazone Clinical Trial in Macrovascular Events
(See PROactive: A Sad Tale of Inappropriate Analysis and Unjustified Interpretation )

RECORD: Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycemia in Diabetes
(See Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.)

RISE: Restoring Insulin Secretion
(See NIH funds studies to improve type 2 and prediabetes treatment)

SEARCH For Diabetes in Youth:
(See SEARCH For Diabetes in Youth)

STAMPEDE: Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently
(See Cleveland Clinic study shows bariatric surgery improves, reverses diabetes )

TEDDY: The Environmental Determinants of Diabetes in the Young
(See TEDDY)

TIDE: Thiazolidinedione Intervention With Vitamin D Evaluation
(See Avandia's TIDE is Turning)

TODAY: Treatment Options for Type 2 Diabetes in Adolescents and Youth
(See Two drugs better than one to treat youth with type 2 diabetes)

TRIGR: Trial to Reduce IDDM in the Genetically at Risk
(See A Finnish study shows for the first time that dietary intervention in infancy can prevent the initiation of the disease process leading to type 1 diabetes among high-risk children )

UKPDS: United Kingdom Prospective Diabetes Study
(See UK Prospective Diabetes Study)

UKPDS~PTM: United Kingdom Prospective Diabetes Study~Post Trial Monitoring
(See UKPDS~PTM home page)

0 - 9

4-T: Treating To Target in Type 2 Diabetes
(See Treating To Target in Type 2 Diabetes Final results)

Advertisement